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Abstract
 
To identify the physiological role of Hck, a functionally redundant member of the Src family
of tyrosine kinases expressed in myelomonocytic cells, we generated Hck
 
F/F
 
 “knock-in” mice
which carry a targeted tyrosine (Y) to phenylalanine (F) substitution of the COOH-terminal,
negative regulatory Y
 
499
 
-residue in the Hck protein. Unlike their Hck
 
 
 
/
 
 
 
 “loss-of-function”
counterparts, Hck
 
F/F
 
 “gain-of-function” mice spontaneously acquired a lung pathology charac-
terized by extensive eosinophilic and mononuclear cell infiltration within the lung paren-
chyma, alveolar airspaces, and around blood vessels, as well as marked epithelial mucus meta-
plasia in conducting airways. Lungs from Hck
 
F/F
 
 mice showed areas of mild emphysema and
pulmonary fibrosis, which together with inflammation resulted in altered lung function and re-
spiratory distress in aging mice. When challenged transnasally with lipopolysaccharide (LPS),
Hck
 
F/F
 
 mice displayed an exaggerated pulmonary innate immune response, characterized by
excessive release of matrix metalloproteinases and tumor necrosis factor (TNF)
 
 
 
. Similarly,
Hck
 
F/F
 
 mice were highly sensitive to endotoxemia after systemic administration of LPS, and
macrophages and neutrophils derived from Hck
 
F/F
 
 mice exhibited enhanced effector functions
in vitro (e.g., nitric oxide and TNF
 
 
 
 production, chemotaxis, and degranulation). Based on
the demonstrated functional association of Hck with leukocyte integrins, we propose that con-
stitutive activation of Hck may mimic adhesion-dependent priming of leukocytes. Thus, our
observations collectively suggest an enhanced innate immune response in Hck
 
F/F
 
 mice thereby
skewing innate immunity from a reversible physiological host defense response to one causing
irreversible tissue damage.
Key words: knock-in mutation • LPS • endotoxemia • macrophage • neutrophil
 
Introduction
 
Hck is a member of the highly conserved Src-family of cy-
toplasmic protein tyrosine kinases that transduce a variety
of extracellular signals, which ultimately affect cellular pro-
cesses including proliferation, differentiation and migration.
Src family kinases (SFKs)
 
*
 
 can be divided into two groups,
 
those that exhibit a relatively ubiquitous pattern of ex-
pression (i.e., Src, Yes, Fyn) and those whose expression is
restricted to the hemopoietic system (e.g., Lck in T lym-
phocytes and Hck in myelomonocytic cell lineages; refer-
ence 1). The well-defined modular structure of SFKs
comprises a relatively divergent, NH
 
2
 
-terminal “unique”
 
Address correspondence to M. Ernst, Ludwig Institute for Cancer Research,
PO Royal Melbourne Hospital, Victoria 3050, Australia. Phone: 61-3-
3941-3149; Fax: 61-3-9341-3191. E-mail: matthias.ernst@ludwig.edu.au
 
*
 
Abbreviations used in this paper:
 
 BAL-F, bronchoalveloar lavage fluid;
BMDM, bone marrow–derived macrophage; ES, embryonic stem; F,
phenylalanine; fMLP, N-formyl-methionyl-leucyl-phenylalanine; MMP,
 
metalloproteinase; NO, nitric oxide; PEEP, positive end expiratory
pressure; PTP, protein tyrosine phosphatase; SFK, Src family kinases;
SRBC, sheep red blood cell; Y, tyrosine. 
590
 
Constitutive Activation of Hck Results in an Enhanced Pulmonary Inflammation
 
domain, which is subject to posttranslational lipid modifi-
cations thereby targeting SFKs to the plasma membrane.
Src homology 3 (SH3) and 2 (SH2) domains, and a tyro-
sine kinase catalytic domain (2) follow the “unique” do-
main. The catalytic activity of SFKs is regulated, both posi-
tively and negatively, by tyrosine phosphorylation of highly
conserved tyrosine (Y) residues. Phosphorylation of a single
conserved Y residue in the COOH terminus of SFKs (e.g.,
Y
 
499
 
 in murine Hck or Y
 
527
 
 in chicken c-Src) by the pro-
tein kinase Csk renders SFKs inactive as a result of an in-
tramolecular interaction between the phosphorylated tyro-
sine (pY) residue and their own SH2 domain. Disruption
of this interaction, either as a result of dephosphorylation,
or substitution of the COOH-terminal regulatory Y resi-
due with phenylalanine (F; e.g., Hck
 
Y499F
 
), or COOH-ter-
minal truncation mutations as observed in the virally trans-
duced v-Src oncoprotein, results in constitutive activation
of SFKs (3–8). In contrast to phosphorylation of the
COOH-terminal regulatory tyrosine residue, autophos-
phorylation of a tyrosine residue within the kinase domain
of SFKs (e.g., Hck
 
Y388
 
) acts to positively regulate their cata-
lytic activity. Thus, activation of SFKs requires both dis-
ruption of the COOH-terminal regulatory tyrosine-SH2
domain interaction and autophosphorylation of the regula-
tory tyrosine residue within the kinase domain.
Unique functions for individual SFKs have been identi-
fied from studies of “loss-of-function” mouse models engi-
neered by the genetic disruption of specific family mem-
bers. However, the phenotypes of the resulting mice were
often subtle due to functional redundancy between indi-
vidual family members, as revealed by the subsequent anal-
ysis of compound knockout mutant mice. In particular, the
full extent of Hck function remains elusive, as the pheno-
type of Hck
 
 
 
/
 
 
 
 mice was confined to a mild defect in F
 
c
 
receptor-independent phagocytic activity of macrophages
(9). Further analysis of Hck deficiency, in the context of
Hck
 
 
 
/
 
 
 
Fgr
 
 
 
/
 
 
 
 and Hck
 
 
 
/
 
 
 
Fgr
 
 
 
/
 
 
 
Lyn
 
 
 
/
 
  
 
compound mu-
tant mice, suggested a much broader, albeit redundant, role
for Hck in neutrophil and macrophage mediated host de-
fense and inflammatory responses (9–10).
Here, we translate into the laboratory mouse a strategy
previously established by us in cultured cells (11) to iden-
tify the physiological functions of an individual member
within a functionally redundant protein family (such as
SFKs) by introducing a constitutively activating “gain-of-
function” mutation into the corresponding endogenous
gene. This strategy ensures, without prior characterization
of the cis-acting regulatory gene sequences, faithful
tempo-spatial recapitulation of the expression pattern of
the wild-type version of the protein. Introduction of
a “gain-of-function” mutation into the 
 
hck
 
 gene (i.e.,
Hck
 
Y499F
 
) resulted in mice that exhibited an enhanced in-
nate immune response, characterized by constitutive prim-
ing of leukocytes and culminating in acquired leukocyte
consolidation in the lung. Additionally, the mice homozy-
gous for this mutation, referred to as Hck
 
F/F
 
 mice, were
highly susceptible to LPS-induced pulmonary and systemic
inflammatory responses.
 
Materials and Methods
 
Targeting Construct and Generation of Mice
 
The “replacement-type” targeting vector p
 
Hck
 
499F-IRESneo
 
 used
in the present study represents a modified version of the previ-
ously described “insertion-type” targeting vector p
 
HCK499F
 
(11). In brief, the 
 
Sal
 
I-
 
Xho
 
I fragment from p
 
HCK499F
 
, encom-
passing 0.8 and 6.6 kb of homologous sequence flanking the last
coding exon of the mouse 
 
hck
 
 gene, was used to introduce the ty-
rosine-499 to phenylalanine substitution (TAT 
 
→ 
 
TTC), as well
as a novel BglII restriction site over the translational stop codon at
amino acid position 504. A BamHI-NheI-BamHI adaptor was
then introduced into the BglII site and a Neo
 
r
 
-IRES cassette in-
serted into the NheI site as a XbaI/NheI fragment.
Twenty-five million W9.5 embryonic stem (ES) cells (129/Sv)
were electroporated with the SalI linearized p
 
Hck
 
499F-IRESneo
 
 tar-
geting construct. 5 out of 92 neomycin-resistant colonies were
found to be correctly targeted, as judged by Southern blotting of
genomic DNA with a fragment mapping upstream of the 5
 
 
 
-end
of the targeting vector. Allele-specific RT-PCR was used to con-
firm the nucleotide sequence of the mutated exon in the targeted
allele. Two recombinant ES cell lines were injected into C57BL/6
blastocysts and the resulting germline chimeras mated with
C57BL/6 females to establish a Hck
 
F/F
 
 breeding colony.
 
Assays on Live Mice
 
LPS-triggered Innate Immunity in Mice.
 
An innate cellular in-
flammatory response was induced by instillation of 10 
 
 
 
g of the
gram-negative bacterial cell-wall component LPS (
 
Escherichia coli
 
Serotype 026:B6 from Sigma-Aldrich; dissolved in 50 
 
 
 
l PBS)
into the lungs of anesthetized mice using a transnasal challenge
method (12). For necropsy, mice were anesthetized with keta-
mine/xylazine (15 mg/kg and 30 mg/kg, intraperitoneally, re-
spectively) and a blood sample withdrawn from the abdominal
aorta. Both total and viable cells counts (using ethidium bro-
mide/acridine orange; Molecular Probes) were performed on
bronchoalveloar lavage fluids (BAL-F) from the lungs of the
mice. Cell types and differential counts were determined accord-
ing to standard morphological criteria on Diff-Quick (Dade Bax-
ter) stained cytospins of undiluted BAL-F. To assess the response
of mice to systemic challenge with LPS, a telemetric temperature
sensor (ELAMS temperature transponder system) was implanted
subcutaneously in the backs of age-, weight-, and sex-matched
mice. 3 d later, mice received a single intraperitoneal injection of
the indicated dose of LPS. The body weight, core body temper-
ature, and survival of the mice were monitored for up to 7 d af-
ter injection.
 
Measurement of Mouse Lung Function.
 
Each mouse was anes-
thetized with 0.1 ml/10 g of a mixture containing xylazine (2
mg/ml; Bayer) and ketamine (40 mg/ml; Parnell Laboratories).
Two-thirds of the dose was given to induce anesthesia, with the
remainder given when the animal was attached to the ventilator.
Top-up doses were given approximately each 40–60 min, as re-
quired. Once surgical anesthesia had been established, a tracheos-
tomy was performed with a polyethylene cannula (10-mm long
and 0.813-mm inner diameter, respectively) inserted. Mice were
ventilated with a tidal volume of 8 ml/kg at a rate of 450 breaths
per minute, with a positive end-expiratory pressure of 0.2 kPa,
using a custom-designed ventilator (
 
flexiVent
 
; Scireq). The special
features of this ventilator include a precision computer-controlled
piston that is capable of accurately producing any desired wave-
form and measuring of the delivered volume (and thus flow) by
tracking the piston movement (with appropriate corrections for 
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gas compression). The animal handling and study protocol con-
formed with the guidelines of the Australian National Health and
Medical Research Council and were approved by the Animal
Ethics Committee of the Institute for Child Health Research.
Lung function was measured during brief pauses (t 
 
 
 
 6 s) of
ventilation, during which the animal was switched from the ven-
tilation circuit to the measurement circuit. A forcing function,
with 25 frequency components between 1 and 25 Hz was gener-
ated by the loudspeaker and delivered to the animal via a wave
tube (length 
 
 
 
 100 cm, inner diameter 
 
 
 
 0.116 cm). The phase
content of the forcing function was optimized to limit the peak-
to-peak amplitude to 2 cm H
 
2
 
O. Measurements were made at
trans-respiratory pressures of 0, 2, 5, 10, 15, and 20 cm H
 
2
 
O. The
measurement circuit was pressurized to the desired pressure be-
fore the animal being switched into the circuit. Approximately 3 s
were allowed for the animal to equilibrate with the measure-
ment circuit before the forcing function was introduced. At each
pressure four discrete data epochs were collected, separated by at
least 30 s of normal ventilation, with a positive end expiratory
pressure (PEEP) of 2 cm H
 
2
 
0. Individual spectra were averaged
and the constant phase model (CPM; reference 13) fitted with
the impedance of the respiratory system (Zrs; Zrs 
 
 
 
 R 
 
 
 
 j
 
 
 
I 
 
 
 
(G 
 
  
 
jH)/
 
 
 
 
 
, where R is the Newtonian resistance (primarily lo-
cated in the airways but containing a contribution from the chest
wall), I is the inertance, G is the coefficient of tissue damping
(which reflects the resistive properties of the lung tissues), H is the
coefficient of tissue elastance (which reflects tissue stiffness), 
 
 
 
 is
the angular frequency, and 
 
 
 
 represents the reciprocal frequency-
dependent behavior of G 
 
 
 
 H.
 
Measurement of Erythrocyte Half-Life.
 
Erythrocytes from C57/
Bl6 mice were labeled with 200 
 
 
 
Ci of Na
 
2
 
[
 
51
 
Cr]O
 
3
 
 (300 mCi/
mg chromium; Amersham Biosciences) as described (14). The la-
beled erythrocytes were diluted with isotonic saline and injected
into the tail vein of 8-wk-old wild-type (i.e., Hck
 
Y/Y
 
) and Hck
 
F/F
 
mice. Approximately 70 
 
 
 
l of blood was subsequently collected
(via saphenous tail vein bleeding) from each recipient mouse 1, 5,
8, 12, 15, and 18 d later. Radioactivity associated with erythro-
cytes was quantitated with a gamma counter.
 
Cell Culture
 
Bone marrow–derived macrophages (BMDMs) were derived
from bone marrow cells aspirated from the femurs of 8- to 12-
wk-old mice. Bone marrow cells were flushed into BM-DMEM
(DMEM supplemented with 10% FCS and 20% L cell-condi-
tioned medium) and cultured in BM-DMEM at 37
 
 
 
C in a hu-
midified atmosphere of 10% CO
 
2
 
. Nonadherent cells were col-
lected 24 h later, resuspended in fresh BM-DMEM and cultured
for an additional 4 to 6 d. PMNs from mouse femurs were aspi-
rated into Ca
 
2
 
 
 
/Mg
 
2
 
 
 
-free HBSS and then purified through a
discontinuous Percoll gradient as described previously (15).
Greater than 95% of the purified cells were positive for the gran-
ulocyte marker Gr-1. Eosinophils were purified, to greater than
95% purity, from BAL-F by lectin affinity selection as described
previously (16).
In experiments where pervanadate was used to inhibit in vivo
protein tyrosine phosphatase activity, sodium orthovanadate (20
mM in water) was mixed 1:4 with H
 
2
 
O
 
2
 
 (30%), incubated for 5
min at room temperature (17) and then immediately added to
BMDMs to a final concentration of 1.5 
 
 
 
M.
Cultured BMDMs were stimulated with the indicated concen-
trations of LPS (1 mg/ml stock solution in PBS containing 1%
FCS) preceded in some cases by priming for 2 h with recombi-
nant murine INF-
 
 
 
 (15 U/ml; Roche Molecular Diagnostics).
 
Cellular Assays
 
In vitro migration of PMNs was assessed using modified Boy-
den chambers (18, 19). In brief, 10
 
5
 
 PMNs were seeded in the
upper chamber of a 24-well dish containing a tissue culture
insert with a porous polycarbonate filter membrane (8 
 
 
 
M; Bec-
ton Dickinson) that had been precoated with 10 
 
 
 
g/ml fibrino-
gen for 1 h at 37
 
 
 
C. The chemotactic peptide N-formyl-
methionyl-leucyl-phenylalanine (fMLP; 200 nM) was then
added to the upper and/or lower chambers in the indicated
combinations. At the specified time, the filter inserts were re-
moved, washed extensively, and the cells attached to the inserts
fixed in 4% paraformaldehyde and stained with Giemsa. The
chemotactic capacity of the PMNs was quantitated by counting
in five randomly chosen fields the number of cells on the under-
side of the filters.
Priming, activation, and degranulation of PMNs, evident from
a progressive gain in “forward scatter” and loss of “side scatter,”
was analyzed by FACS
 
®
 
 (20). In brief, PMNs were resuspended
in PBS containing 0.2% BSA and 5 mM glucose, or in some cases
adhered to fibrinogen-coated 24-well plates for 30 min at 37
 
 
 
C,
and then stimulated at 37
 
 
 
C with TNF
 
 
 
 (20 ng/ml) or PMA (1
 
 
 
g/ml). After fixation with ice-cold 8% formaldehyde in PBS,
the cells were stained with a Gr-1 antibody and analyzed by
FACS
 
®
 
. Gr-1
 
hi cells were gated and both “forward” and “side”
scatter profiles analyzed.
Release of nitric oxide by LPS-stimulated BMDMs and reac-
tive oxygen species (i.e., O2
 ) by TNF  (20 ng/ml) or fMLP
(200 nM) stimulated PMNs was as described previously by Stuehr
et al. (21) and Berton et al. (22), respectively. The values were
corrected for the number of live cells in each well as assessed by
MTT stain.
The capacity of BMDMs to phagocytose either opsonized or
nonopsonized sheep red blood cells that had been labeled with
Na2[51Cr]O3 was performed according to a standard procedure
(23).
Immunoblotting, In Vitro Kinase Assays and Zymography
Cells were lysed directly in lysis buffer (1% Triton X-100, 0.1%
SDS, 10% glycerol, 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2
mM EDTA, 1 mM Na2VO3, 50 mM NaF, and complete protease
inhibitors) for 30 min on ice. Lysates were clarified by centrifuga-
tion at 13,000 g for 10 min at 4 C, and protein concentrations
measured with a BCA protein assay kit (Pierce Chemical Co.).
Immunoblotting and immunoprecipitation of cell lysates was per-
formed by standard techniques. The anti-phosphotyrosine (4G10;
UBI), anti-Hck rabbit polyclonal (from C. Lowell, University of
California at San Francisco, San Francisco, CA) and rat mono-
clonal (24), anti-Lyn (Santa Cruz Biotochnology, Inc.), anti-
iNOS (Santa Cruz Biotochnology, Inc.), Gr-1 (BD Biosciences),
anti-cbl (W. Langdon, University of Western Australia, Perth,
Australia), anti-paxillin (Zymed Laboratories), and anti-SHP-1
(from H.-C. Cheng, University of Melbourne, Melbourne, Aus-
tralia) antibodies were from the indicated sources.
The in vitro kinase activity of Hck was assessed in immuno-
precipitates of whole cell lysates and equalized for Hck protein.
The immunoprecipitates were washed three times with lysis
buffer, then once with kinase wash buffer (20 mM Hepes, pH
7.4, 0.1% NP-40, and 0.1 mM sodium orthovanadate). The im-
munoprecipitates were then incubated at room temperature for
10 min in 30  l of kinase buffer (20 mM Hepes, pH 7.4, 10 mM
MnCl2, 0.1% NP-40, and 0.1 mM sodium orthovanadate) con-
taining 10  Ci [ -32P] ATP (25). Reactions were terminated by
the addition of an equal volume of 2  SDS-PAGE sample buffer592 Constitutive Activation of Hck Results in an Enhanced Pulmonary Inflammation
and heating for 5 min at 95 C. Phosphorylated proteins were re-
solved by SDS-PAGE and subsequently analyzed using a Phos-
phorImager screen (Molecular Dynamics).
Zymography was used to assess total protease activity in BAL-F
from LPS-treated mice. Specifically, 100  l of BAL-F was con-
centrated by precipitation with trichloroacetic acid and then re-
suspended in nonreducing SDS-PAGE sample buffer. The sam-
ples were then applied to 10% SDS-PAGE gel slabs containing
either  -casein (2 mg/ml; Sigma-Aldrich) or gelatin (2 mg/ml;
Labchem). After electrophoresis, gels were removed and washed
twice in 2.5% Triton X-100 and then incubated overnight at
37 C in zymography buffer (50 mM Tris, pH 7.5, 5 mM CaCl2,
1 mM ZnCl2, 0.01% NaN3). The gels were then stained for 45
min with Coomassie Brilliant Blue 250-R (Sigma-Aldrich), fol-
lowed by extensive destaining. Protease activity is indicated by
regions of negative staining.
Northern Blot Analysis
Northern blotting of poly(A)  RNA isolated from BMDM
cells and mouse spleens was performed by standard techniques.
Histology
To ensure consistent morphological preservation of lungs,
mice were anesthetized and then perfusion fixed via a tracheal
cannula with 4% formaldehyde at exactly 200 mm H2O pressure
for 4 h at room temperature. Fixed tissues were embedded in par-
affin and sections stained either with hematoxylin and eosin, Al-
cian Blue/periodic acid-Schiff to stain mucus, or trichromic acid
to detect extracellular matrix. All histological assessments were
performed blind.
ELISA
Mouse TNF , IL-5, and eotaxin levels were determined by
interpolation of standard curves using standard sandwich ELISA
(R&D Systems Quantikine for TNF  and BD Biosciences anti-
body pairs for IL-5 and eotaxin). All limits of detection were 10
ng/ml.
Results
Generation of HckF/F Mice. To generate mice that ex-
press a constitutively active mutant of Hck (i.e., HckY499F),
we used gene targeting in ES cells to introduce a tyrosine
(Y499) to phenylalanine (F) substitution in exon 13 of the
endogenous hck gene. The promoterless, bicistronic target-
ing vector pHCK499F-IRESneo contains 0.8 kb of intron 12
and 6.6 kb of 3  homologous sequences flanking the mu-
tant exon 13 with the Y499F substitution (TAT → TTC),
and an IRES-neomycin resistance cassette (Fig. 1 a). This
strategy was adopted to take advantage of the fact that the
hck promoter is active in ES cells (11) and to ensure that the
bicistronic mutant hckF-IRESneo RNA species contained
all the 3 -UTR sequence information that might normally
regulate the stability of endogenous wild-type hckY mRNA
transcripts. Targeted heterozygous HckY/F ES cells, recov-
ered at a frequency of 1 in 19 antibiotic-resistant ES cell
colonies, gave rise to germline-transmitting chimeric mice
upon injection into host blastocysts. Interbreeding of het-
erozygous offspring yielded fertile homozygous mutant
(HckF/F) mice at the expected Mendelian ratio (unpub-
lished data). The mice were of normal appearance and had
an average life span of 22   4 mo when housed in a con-
ventional animal facility.
Elevated Hck Kinase Activity in Cells Derived from HckF/F
Mice. To assess the impact of this “gain-of-function” mu-
tation into the hck gene on tyrosine phosphorylation of
proteins in myelomonocytic cells, whole cell lysates of
BMDMs derived from both mutant HckF/F and wild-type
(HckY/Y) mice were subjected to Western blotting with
anti-Hck and anti-phosphotyrosine antibodies. Signifi-
cantly, we reproducibly detected reduced (approximately
fourfold) levels of both isoforms of Hck in BMDMs and
other primary myelomonocytic cell types derived from
HckF/F mutant mice when compared with those from
HckY/Y mice (Fig. 1 b). By contrast, the protein levels of
the related Src-family kinase Lyn were not affected in
BMDMs derived from HckF/F mutant mice. The specific
reduction of HckF protein was correlated with reduced
steady-state RNA level of hckF-IRESneo transcripts in
BMDMs (Fig. 1 c) and in the spleen (unpublished data)
when compared with wild-type hckY RNA. However, we
determined similar RNA stability of hckF-IRESneo and
hckY transcripts in the presence of the RNA polymerase
II inhibitor 5,6-dichloro-1 -D-ribofuranosylbenzimidazole
(unpublished data). Despite reduced levels of HckF protein
in whole cell lysates of the BMDMs, we observed modestly
increased levels of overall tyrosine phosphorylation in a
manner dependent on the dosage of the mutant gene (Fig.
1 d). Furthermore, in vitro kinase assays performed on
equalized amounts of Hck protein, revealed a three- to
fivefold increase in the specific activity of the HckF protein
(Fig. 1 e). By contrast, Hck immunoprecipitated from
HckY/Y BMDMs did not exhibit any detectable tyrosine
phosphorylation when using the phosphotyrosine-specific
antibody 4G10 (Fig. 1 e, top panel). This finding suggests
endogenous protein tyrosine phosphatases (PTPs) act to
keep HckF in an un-(auto)phosphorylated state (26),
thereby suppressing to some extent its catalytic activity. To
test this notion, BMDMs from HckF/F mice were treated
with the pan-PTP inhibitor pervanadate. As shown in Fig.
1 f, pervanadate treatment dramatically enhanced the levels
of tyrosine phosphorylation of cellular proteins, including
that of the bone fide Hck-substrates c-Cbl and paxillin (27)
in BMDMs from HckF/F mice (Fig. 1 g). Collectively,
these results confirm that the Y499F mutation introduced
into the endogenous hck gene results in the expression of a
constitutively active form of Hck. However, as a result of
the counteracting mechanisms (reduced steady-state level
of HckY protein, elevated activity of endogenous PTPs),
the kinase activity of Hck is only moderately elevated in
HckF/F “gain-of-function” mice (Fig. 1 e).
Pulmonary Pathology in HckF/F Mice. HckF/F mice ap-
peared superficially healthy throughout their adult life.
Upon histological examination, however, the lungs of all
adult HckF/F mice (3–4 mo and older) showed areas of
atelectasis, inflammatory infiltration into the interstitium
and alveoli, and some areas of enlarged airspaces. These
lungs were consistently characterized by increased cellular-
ity within the parenchyma, accumulation of mononuclear593 Ernst et al.
inflammatory cells in areas around airways, alveolar air-
spaces, and blood vessels, as well as by the presence of large
macrophages despite specific pathogen-free (SPF)-housing
(Fig. 2, a and b). Eosinophils represented the most promi-
nent cell type within the infiltrates (30   9% of total
BAL-F cells in HckF/F mice versus 2   1% in HckY/Y mice).
Additionally, spiculate crystalline forms, likely to represent
degranulated eosinophilic protein, often accompanied the
eosinophilic matter in the alveolar spaces as well as en-
gulfed crystalline eosinophilic material was frequently ob-
served in macrophages (see below). The epithelium lining
conducting airways was frequently hypertrophic and many
epithelial cells were enlarged due to excessive production
and/or accumulation of mucus material (Fig. 2, c and d).
Furthermore, lungs from HckF/F mice showed areas of
mild emphysema, as histologically evident from alveolar
enlargement with the loss of the orderly appearance of the
acinus, and signs of fibrosis characterized by deposition of
extracellular matrix in the alveolar septa (Fig. 2, e and f).
Concomitantly, BAL-F recovered from the lungs of mu-
tant mice revealed elevated levels of IL-5 (70   27 pg/ml
in HckY/Y versus 17   5 pg/ml in HckY/Y) and eotaxin
(37   8 pg/ml in HckY/Y versus 23   4 pg/ml in HckY/Y),
features associated with eosinophilia (28, 29). At weaning,
lungs of HckF/F mice were indistinguishable from those of
HckY/Y mice (Fig. 3, a and b). Irrespective of whether
mice were housed in a conventional or a SPF-environ-
ment, areas of localized pulmonary consolidations became
evident around  5-6 wk of age in HckF/F mice and pro-
gressed thereafter (Fig. 3, c and d). In rare cases, pulmo-
nary adenocarcinomas were detected in HckF/F mice ap-
proaching 2 yr of age (Fig. 3, e and f).
Assessment of Lung Function in HckF/F Mice. To assess
the functional consequences of the extensive lung paren-
Figure 1. Generation of
HckF/F mice and biochemical
analysis of HckF/F BMDMs. (a)
Gene targeting strategy for intro-
ducing the Y499F mutation into
the endogenous hck gene in ES
cells. A region of the murine hck
gene is schematically depicted
with numbers of the coding ex-
ons (boxes) and the 3-UTR.
The targeting vector pHCK499F-
IRESneo contains the TAT to TTC
substitution in the nucleotide
triplet encoding amino acid 499,
a stop codon, and an IRES-neo-
mycin resistance (IRESneo) cas-
sette. A diagnostic digest with
BamHI (Ba) yields a fragment of
7.5 kb from the wild-type allele
and a 2.4-kb fragment from the
targeted allele when hybridized
with a probe external to the tar-
geting vector (marked by *). (b)
Reduced levels of HckF protein
in BMDM. Equal amounts of
total cell lysates derived from
mice of the indicated genotypes
were subjected to Western
blotting with anti-Hck antibody.
The blot was stripped and re-
probed with an anti-Lyn anti-
body. Arrows indicate the posi-
tions of the p59/p56 Hck and
p56/p53 Lyn isoforms, respec-
tively. (c) Northern blot
analysis of BMDM RNA.
Poly(A) RNA was hybridized
with a full-length cDNA clone
encoding murine Hck. Dicis-
tronic hckF-IRESneo mRNA transcripts are  1.4 kb larger than the wild-type hck mRNA transcripts. A gapdh probe was subsequently used to assess
RNA loading. (d) Elevated levels of tyrosine-phosphorylated proteins in HckF/F mutant cells. Total cell lysates from BMDMs derived from mice of the
indicated genotypes were subjected to Western blotting with anti-phosphotyrosine (pY) antibodies. The blot was then stripped and reprobed with an
anti-Hck antibody. (e) HckF exhibits elevated activity in vitro. Equalized amounts of Hck were immunoprecipitated from lysates of BMDMs (bottom
panel) and subjected to either Western blotting with anti-phosphotyrosine (pY) antibody (top panel) or an auto-phosphorylation assay in the presence of
 -[32P]-ATP (middle panel). (f) Enhanced tyrosine-phosphorylation in BMDMs in the presence of pervanadate. Total cell lysates prepared from BMDMs
that had been cultured in the presence or absence of 1.5  M pervanadate (VO4) were subjected to Western blotting with an anti-pY antibody. (g) The
lysates used in f were also used to analyze tyrosine-phosphorylation of the Hck substrates c-Cbl and paxillin. 1 mg of total cell lysate was immunoprecip-
itated with the indicated antibody and then subjected to Western blotting with an anti-pY antibody. Stripped blots were subsequently reprobed with
anti-Cbl and anti-paxillin antibodies to confirm equal protein loading.594 Constitutive Activation of Hck Results in an Enhanced Pulmonary Inflammation
Figure 2. Histological analysis of lungs from HckF/F mice. Cross sections of lungs collected from HckY/Y mice (a, c, and e) and HckF/F mice (b, d, and f) at 3
mo of age. Mutant lungs consistently showed accumulation of monocytes and macrophages in the alveolar airspaces in lungs of HckF/F mice (b and f). Alveolar
macrophages in mutant lungs were frequently vacuolated (b and d; arrowheads) with eosinophilic cytoplasm (panel b inset; arrows). Epithelial cells lining the
conducting airways of mutant mice displayed extensive mucus cell metaplasia (blue/purple stain in d; white arrow) resulting in mucus aggregates in the airway lu-
men (d, black arrow) when compared with wild-type mice (c). Mutant lungs were characterized by excessive fibrotic deposits of extracellular matrix in the alve-
olar septa (pale green stain in f, arrow). Histological stains were hematoxylin and eosin (a and b), alcian blue/periodic acid-Schiff (c and d), or Masson’s trichrome
(e and f). Bar   40  m.595 Ernst et al.
chymal inflammation, we analyzed pulmonary mechanics
by the low-frequency forced oscillation technique (13,
30). Consistent with the major histological changes affect-
ing the parenchyma, no differences in baseline resistance
(Raw) or the coefficient of tissue damping (G) were ob-
served between mice of the two genotypes (Fig. 4).
However, HckF/F mutant mice showed decreased tissue
elastance of the lung tissue (H) at baseline (PEEP   2 cm
Figure 3. Acquired pulmonary changes in HckF/F mice. Cross sections of lungs collected from HckY/Y mice (a and c) and HckF/F mice (b, d, e, and f).
The lungs of mutant mice look histologically indistinguishable at weaning age (a and b), but show the characteristic accumulation of macrophages and eo-
sinophils (arrow) by 6 wk of age (c and d). Occasionally, old mutant mice ( 2 yr of age) develop pulmonary adenocarcinoma (e and f). Panel f represents a
magnification of the boxed area in e and shows well-differentiated adenocarcinoma composed of irregular glands lined by neoplastic epithelial cells (arrow-
head). Note the extensive consolidation in the nonmalignant sections of the lung (e). Histological stains were hematoxylin and eosin. Bar   100  m.596 Constitutive Activation of Hck Results in an Enhanced Pulmonary Inflammation
H2O) compared with HckY/Y wild-type mice. It is highly
likely this pathological stiffening of the lungs at low to me-
dium lung volume directly results from the inflammatory
infiltrates, thickening of alveolar septa and areas of
atelectasis. These differences disappeared at PEEP lung
volumes approaching total lung capacity, as atelectatic ar-
eas become reinflated. As the shape of the volume-pres-
sure curve and tissue stiffness for lungs approaching their
total capacity more readily reflects the tension skeleton
(which spreads throughout the lung in an organized fash-
ion and consists of collagen and elastin fibers), our data
suggest that there were no major abnormalities in the axial
skeleton of the lungs in HckF/F mutant mice. These clini-
cal features were consistently observed in aging HckF/F
mice, which frequently showed signs of respiratory distress
as evident by their use of accessory muscles. Notably, the
pulmonary changes observed in HckF/F mice are reminis-
cent of some of the features associated with asthma and
chronic obstructive pulmonary disease in humans.
Enhanced Pulmonary Innate Immune Response in HckF/F
Mice. The acquired pulmonary pathology in HckF/F mice
and the proposed involvement of Src family kinases in in-
flammatory reactions (10, 19), suggested the underlying
cause of the lung pathology in HckF/F mice is an enhanced
innate immune response that results in a mild but chronic
pulmonary inflammation process. To test this hypothesis,
we elicited an acute and local inflammatory response in the
lungs of mice by transnasally instilling LPS. Such a pulmo-
nary challenge with LPS elicits a rapid and transient neu-
trophilic inflammatory response, followed by macrophage
invasion into the alveolar spaces (31). Although no differ-
ence between the basal number of neutrophils in the BAL-F
of unchallenged HckF/F and HckY/Y mice was observed,
the extent of neutrophilic accumulation in BAL-F of LPS-
challenged HckY/Y mice, which peaked  24 h after chal-
lenge, was threefold higher than that seen in BAL-F from
identically treated HckF/F mice (Fig. 5 a). By contrast, the
number of macrophages and eosinophils in BAL-F from
unchallenged HckF/F mice were profoundly elevated in
comparison to those detected in BAL-F from unchallenged
HckY/Y mice, with macrophages accounting for about one-
third of all cells recovered in BAL-F from HckF/F mice.
Challenging HckF/F or HckY/Y mice with LPS led to a
comparable relative increase (approximately twofold) in the
number of macrophages in BAL-F, while the LPS chal-
lenge had little effect on the number of eosinophils in
BAL-F of mice of either genotype. Interestingly, we ob-
served a transient decrease in the number of macrophages,
and to a lesser extent eosinophils, in the BAL-F from mice
of either genotype 2 h after LPS challenge, possibly due to
their homotypic interactions and increased leukocyte adhe-
sion to the lung epithelium. As macrophages and neutro-
phils, rather than eosinophils, are traditionally thought to
be the major hemopoietic cell types expressing Hck, we
compared Hck activity associated with equal numbers of
fractionated BAL-F cells of unchallenged HckF/F mice.
This analysis revealed approximately threefold higher ki-
nase activity associated with the eosinophil fraction when
compared with the lectin-extracted mixture of neutrophils
and macrophages (Fig. 5 b), thereby possibly suggesting a
cell-autonomous effect of Hck in eosinophils. Further-
more, analysis of BAL-F from LPS-challenged HckF/F
mice, but not from similarly challenged HckY/Y mice, re-
vealed a rapid and transient increase in levels of the proin-
flammatory cytokine TNF  (Fig. 5 c), a finding consistent
with the enhanced leukocyte accumulation in the lungs of
HckF/F mice.
The sustained presence of inflammatory cells in the lungs
of HckF/F mice is likely to trigger enhanced turn-over of
pulmonary tissue, possibly culminating in emphysema. As
metalloproteinases (MMPs) are critical components in the
continual remodeling of alveolar tissues and are implicated
in emphysema and leukocyte diapedesis, we used zymogra-
phy to investigate MMP-2 and MMP-9 activity in BAL-F
from LPS-challenged mice. Analysis of BAL-F from LPS-
challenged HckF/F mice revealed exaggerated induction of
MMP-2 and MMP-9 activity when compared with that
detected in BAL-F from LPS-challenged HckY/Y mice (Fig.
5 d). Similarly, serine protease activity, which largely re-
flects neutrophil elastase activity, was elevated in BAL-F
from HckF/F mutant mice when compared with HckY/Y
mice (unpublished data).
Figure 4. Impaired lung function in HckF/F mice. Lung function anal-
ysis by oscillatory mechanics indicated that despite intense inflammation
and incipient emphysema, HckF/F mice did not have increased baseline
resistance (Raw) or marked altered tissue damping (G) when compared
with wild-type mice. However, mutant lungs were stiffer (increased tissue
elastance, H), particularly at low lung volumes, possibly resulting from
extensive pulmonary consolidation. Mean   SD (n   6); *P   0.05.597 Ernst et al.
Increased Sensitivity of HckF/F Mice to Systemic Endotox-
emia. Although there has been conflicting evidence for
the redundant involvement of Hck, Lyn, and Fgr in the
endotoxic response (10, 19), our data clearly indicated an
enhanced sensitivity to LPS in the lungs of mice expressing
a constitutively active form of Hck. To extend this obser-
vation, we monitored the sensitivity of HckF/F mice to en-
dotoxemia after systemic administration of a single dose of
LPS. A dose–response survival study following age-,
weight-, and genetic background-matched adult mice over
5 d revealed survival of more than 50% of HckY/Y mice
treated with 24 mg/kg of LPS. By contrast, HckF/F mice
showed 80% mortality at this dose of LPS, while adminis-
tration of 12 mg/kg of LPS resulted in  50% mortality in
these mice (Fig. 6 a). To characterize altered susceptibility
of HckF/F mice to sublethal doses of LPS, we attempted to
objectively monitor LPS-associated illness in terms of
changes in the body weight and core body temperature
registered with an implanted telemetric thermometer de-
vice. After a single challenge with LPS, surviving HckF/F
mice showed exacerbated weight loss and hypothermia
(which is a rodent-specific response to LPS; Fig. 6 b), as
well as profoundly elevated levels of circulating TNF  6 h
post LPS (8 mg/kg) administration (30.8 ng/ml   13.2
ng/ml in HckF/F mice versus 1.5 ng/ml   1.3 ng/ml in
HckY/Y mice).
Elevated LPS-responsiveness of HckF/F Macrophages In Vi-
tro. The above in vivo data suggested that the enhanced
susceptibility of HckF/F mice to LPS might be a conse-
quence of the hyperactive nature of their leukocytes, in
particular macrophages and neutrophils. We therefore ana-
lyzed biological markers that correlate with the activation
of BMDMs by LPS, including the release of the anti-
microbial agent nitric oxide (NO) and the pro-inflamma-
tory cytokine TNF . We observed that BMDMs derived
from HckF/F mice generally showed enhanced sensitivity
to low concentrations of LPS, irrespective of whether the
cells had been primed with IFN- , and that the response
of mutant BMDMs to higher concentrations of LPS was
enhanced by two to threefold (Fig. 7, a and b). The in-
creased release of NO into the culture medium of LPS-
stimulated BMDMs from HckF/F mice is likely to be
explained by the increased expression of inducible nitric
oxide synthetase (iNOS; Fig. 7 c). Comparison of these
activation parameters between naive, unprimed BMDMs
from HckF/F mice and IFN- –primed BMDMs from HckY/Y
mice suggested that the expression of constitutively active
HckF might result in cell-autonomous priming of BMDMs.
Consistent with this hypothesis, the spontaneous release of
NO or TNF  by BMDMs from HckF/F mice was not de-
tected (unpublished data).
Enhanced Phagocytosis by HckF/F Macrophages. The phago-
cytic activity of macrophages is crucial for the clearance
of leukocytes at sites of inflammation and tissue injury.
Electron microscopic analysis of alveolar macrophages in
HckF/F mice revealed the abundant presence of spiculate
crystalline matter highly reminiscent of Charcot-Leyden
crystals (32) within the cells (Fig. 8, a and b). Similarly, his-
Figure 5. Enhanced pulmonary innate immune response in HckF/F
mice. (a) Cellular composition of BAL-F cells from mutant HckF/F (filled
symbols) and wild-type HckY/Y mice (open symbols) of 10 wk of age after
transnasal challenge with LPS (10  g/mouse). BAL-F was collected as de-
scribed in Materials and Methods and cells from eight mice were counted
and classified by their morphological appearance in cytospins. Mean  
SD,  *P     0.01. Data were analyzed by oneway analysis of variance
(ANOVA) followed by Newman-Kreuls multiple comparison tests. (b) In
vitro Hck-kinase activity of leukocytes. PMNs were collected from the
bone-marrow of adult HckF/F and HckY/Y mice, whereas total BAL-F
cells came only from lungs of unchallenged adult HckF/F mice, as BAL-F
of HckY/Y contains negligible numbers of eosinophils. The eosinophil-
enriched (Eos) population represented the lectin-bound proportion of to-
tal BAL-F cells (tot) as described in Materials and Methods. 500  g of cell
lysate was then immunoprecipitated with an anti-Hck antibody and in
vitro autokinase assays were performed in the presence of  -[32P]-ATP.
(c) TNF  levels in BAL-F from LPS-challenged mice. After a single trans-
nasal challenge with LPS (10  g/mouse), levels of TNF  in BAL-F from
HckF/F and HckY/Y mice (three mice of each genotype per experiment)
were measured. Filled symbols: HckF/F mice, open symbols: HckY/Y
mice. (d) MMP-9 and MMP-2 activity in BAL-F from LPS-challenged
mice. After a single transnasal challenge with LPS (10  g/mouse), BAL-F
was recovered from the mice at the indicated time points and MMP-9
and MMP-2 activity was assayed by zymography using gelatin and casein
as the respective substrates. Zones of MMP activity appear as unstained
bands corresponding to the apparent molecular weights of MMP-2 and
MMP-9, respectively.598 Constitutive Activation of Hck Results in an Enhanced Pulmonary Inflammation
tological signs of erythro-phagocytosis were also abun-
dantly apparent in alveolar macrophages (Fig. 8 c) and cir-
culating peripheral blood monocytes from HckF/F mice,
which coincided with mild reticulocytosis in these mice
(unpublished data). Thus, we assessed the in vivo half-life
of  51Cr-labeled erythrocytes in both HckF/F and HckY/Y
control mice. As shown in Fig. 8 d, the extrapolated half-
life of erythrocytes in HckY/Y mice was  31 d, whereas the
half-life of erythrocytes in HckF/F mice was  22 d. Collec-
tively, these observations suggested that monocytes and
macrophages in HckF/F mice have enhanced phagocytic ac-
tivity. Indeed, when compared with BMDMs derived from
HckY/Y mice, BMDMs from HckF/F mice exhibited an en-
hanced ability to phagocytose nonopsonized sheep red
blood cells (SRBCs; Fig. 8 e). By contrast, no difference in
the phagocytic activity of BMDMs from wild-type and
HckF/F mice toward opsonized SRBCs was detected, a
finding consistent with an earlier report that Fc-receptor-
mediated uptake of particles is Hck-independent mice (9).
Enhanced Activity of Neutrophils from HckF/F Mice Is Depen-
dent on Cell Adhesion. The enhanced innate immune re-
sponse of leukocytes observed after LPS administration to
HckF/F mice, and the functional association of Hck with
leukocyte integrins prompted us to investigate the adhesive
and migratory properties of isolated polymorphic neutro-
phils (PMNs) on the  2-integrin ligand fibrinogen. When
assayed in Boyden chambers, PMNs derived from HckF/F
mice had a modestly enhanced migratory capacity when
compared with PMNs from wild-type mice (unpublished
data). However, this difference became more pronounced
when the capacity of the PMNs to migrate along a gradient
of the chemotactic peptide fMLP was assessed (Fig. 9 a).
Similarly, BMDMs derived from HckF/F mice exhibited an
enhanced capacity to migrate when tested in in vitro
“wound-healing” assays (unpublished data).
The pronounced endotoxemic response of HckF/F mice
to LPS is a likely consequence of enhanced activation and
degranulation of PMNs. We therefore undertook FACS®
analysis of bone marrow cells to characterize the in vitro
activation of PMNs from HckF/F and HckY/Y mice by
TNF . Cytokine-dependent PMN activation (and prim-
ing) typically results in an increase in cell size (as evidenced
by an increase in “forward scatter”), whereas degranula-
tion results in a decrease in “side scatter” (20). By arbi-
trarily setting the FACS® gates so that less than 10% of all
unstimulated, Gr1hi cells (i.e., PMNs) of either genotype
fell within the lower right quadrant, we were able to mon-
itor TNF  activation of PMNs by quantifying the increase
in the proportion of PMNs (Fig. 9 b, left panel). When
preadhered to fibrinogen-coated plates, this response was
markedly enhanced in PMNs isolated from HckF/F mice
when compared with cells obtained from HckY/Y mice
Figure 6. Enhanced susceptibility of
HckF/F mice to systemic LPS-challenges. (a)
Reduced survival of HckF/F mutant mice
compared with HckY/Y wild-type mice after
a single intraperitoneal injection of LPS at 6
mg/kg ( ); 12 mg/kg ( ); 16 mg/kg ( )
or 24 mg/kg ( ) and a 5 d observation pe-
riod for survival. Five mice were used per
treatment group. (b) Enhanced morbidity of
HckF/F mice in response to administration
of sublethal amounts of LPS. 3 d before LPS
administration, a telemetric temperature-
measuring device was implanted subcutane-
ously in the back of mice and temperature
and weight recorded at the indicated time
points after a single intraperitoneal injection
of LPS at 2 mg/kg (U); 4 mg/kg ( ); 8 mg/
kg ( ) or vehicle ( ). Each curve repre-
sents the median of five mice per group, ex-
cept for the 8 mg/kg HckF/F group which
only depicts the results from the three sur-
viving mice.599 Ernst et al.
(Fig. 9 b, right panel). By contrast, the difference in the
activation response was less pronounced between PMNs
isolated from HckF/F and HckY/Y mice when the cells were
kept in suspension during activation with TNF . Simi-
larly, PMN degranulation induced by PMA, which is in-
dependent of cell adhesion to extracellular matrix proteins
(33), was indistinguishable between cells derived from
HckF/F or HckY/Y mice (Fig. 9 b). Finally, the ability of
PMNs isolated from HckF/F and wild-type mice to elicit
cytokine-induced superoxide (O2
 ) production, an adhe-
sion-dependent process (34), was investigated. As revealed
in Fig. 9 c, PMNs from HckF/F mice released approxi-
mately twofold more superoxide in response to TNF  or
fMLP stimulation than did their wild-type counterparts
when plated on fibrinogen-coated microtiter plates. By
contrast, no significant difference in superoxide produc-
tion was observed between PMNs of the two genotypes
when plated on uncoated microtiter plates (unpublished
data). Collectively, these data suggest latent priming of
PMNs from HckF/F mice which results in their enhanced
adhesion-dependent activation in response to inflamma-
tory cytokines such as TNF .
Discussion
To define the physiological function(s) of the Src family
kinase Hck, we have used a “knock-in” gene targeting
strategy to introduce a hypermorphic, “gain-of-function”
mutation into the hck allele in the germline of mice. This
approach ensured that all the cis-acting elements of the hck
gene, which collectively serve to regulate its temporal and
spatial expression patterns, remained intact. Thus, we can
confidently attribute all the phenotypic alterations in the
resulting HckF/F mice to deregulated Hck kinase activity
rather than to the aberrant and/or ectopic expression of a
transgene, which is a limitation of traditional transgenic
“gain-of-function” mouse models. The latter point is sig-
nificant in light of the finding that transgenic expression of
constitutively active mutants of the SFK c-Src (35, 36), Lck
(37), or Blk (38) result in tumorigenesis at the site of trans-
gene expression. By contrast, we find no evidence for
cellular transformation as a primary consequence of intro-
ducing a constitutively activating mutation into the endog-
enous loci of the murine hck (herein) or lyn genes (26), al-
though we cannot exclude that Hck activity in the HckF/F
knock-in mice may be below that required for tumor for-
mation. Remarkably, deregulated Hck kinase activity re-
sulted in a plethora of Hck-specific cellular activities and
patho-physiological responses that were hitherto masked by
functional redundancy among SFKs in Hck “loss-of-func-
tion” mutant mice.
Requirement for Tight Control of Hck Activity. Our bio-
chemical analysis of BMDMs and neutrophils isolated from
HckF/F mice revealed only a small increase in net-tyrosine
phosphorylation of endogenous proteins and a relatively
modest increase in cellular activation of leukocytes follow-
ing acute in vitro stimulation. However, the highly repro-
ducible occurrence and progression of the pulmonary
disease observed in HckF/F mice illustrates the severe
patho-physiological consequences arising from the cumula-
tive effects of apparently subtle alterations in the innate im-
mune response. We therefore propose that the careful and
tight control of the catalytic activity of Hck is a critical de-
terminant in preventing the destruction of host organs
(e.g., lung) by an inappropriate innate immune response
(e.g., chronic inflammation). Unlike tyrosine phosphoryla-
tion-dependent signal transduction events emanating from
growth factor receptors that are often terminated by inter-
nalization of the ligand-bound receptor complex, integrin-
mediated “outside-in” signaling may be limited through
the inactivation of integrin-associated tyrosine kinases (e.g.,
Figure 7. Exaggerated in vitro response of BMDMs to LPS. (a and b)
Release of NO2
  (a) and TNF  (b) by BMDMs, derived from 8-wk-old
HckF/F and HckY/Y mice and exposed to the indicated amount of LPS for
48 h. Where indicated, the cultures were primed with IFN-  (15 U/ml)
2 h before LPS treatment. Values are the median of quadruplicate cul-
tures. (c) Induction of nitric oxide synthetase protein (iNOS) in LPS-
treated BMDMs of HckF/F and HckY/Y mice was assessed by Western
blotting of 50  g of total cell lysates after a 24-h stimulation with LPS at
the indicated concentration.600 Constitutive Activation of Hck Results in an Enhanced Pulmonary Inflammation
SFKs). The catalytic activity of the SFK Hck for example,
is tightly regulated by the coordinated phosphorylation of
the key regulatory Y388 and Y499 residues, which ensure
that temporal changes in kinase activity remain within
physiological levels. Our analysis of HckF-expressing cells
suggests that the cellular machinery attempts to counteract
the inappropriately activated tyrosine kinase by several
mechanisms: (a) reducing the steady-state levels of hckF
transcripts; (b) reducing the expression level of the HckF
protein (possibly via an ubiquitin- and proteasome-depen-
dent degradation pathway (39); and (c) by activating PTPs
capable of inactivating Hck. The finding that HckF is not
significantly tyrosine phosphorylated in BMDM derived
from HckF/F mice and that treatment of these BMDMs
with the PTP inhibitor pervanadate enhanced tyrosine
phosphorylation of cellular proteins argues that PTPs play a
significant role in suppressing the catalytic (signal transduc-
ing) activity of the mutant HckF. Intriguingly, mice ho-
mozygous for the mev hypomorphic allele of SHP-1 ex-
hibit spontaneous consolidation of the lung with myeloid
cell infiltrates independent of T and B lymphocytes (40, 41)
that are remarkably similar in appearance to the leukocyte
infiltrates observed in the lungs of HckF/F mice. In addi-
tion, BMDMs isolated from mev/v mice adhere and spread
to a greater extent through  2-integrin mediated contacts
than do their wild-type counterparts (42), and our prelimi-
nary observations suggest hyperphosphorylation (and acti-
vation) of SHP-1 in HckF/F cells (unpublished data). Simi-
larly, the lack of CD45, which dephosphorylates the
autocatalytic Y-residue of Hck and Lyn during integrin
mediated-adhesion, results in enhanced adhesion of BMDMs
in vitro (43).
Figure 8. Enhanced phagocytic activity of HckF/F macrophages. (a–c) Electron
micrographs of alveolar macrophages from HckF/F mice showing the presence of
eosinophilic crystals (a, original magnification  25,000), which are often associ-
ated with secondary lysosomes (b; arrowhead, original magnification  50,500),
and frequently contain ingested erythrocytes (c; arrowhead, original magnifica-
tion  25,000). (d) Half-life of erythrocytes in HckF/F and HckY/Y mice. Levels of
51Cr-labeled erythrocytes in the peripheral blood of HckF/F and HckY/Y mice
were determined at the indicated time points after transfusion. The amount of ra-
dioactivity associated with erythrocyte 30 min after transfusion was taken as
100%. The data represent means   SD (n   10). (e) Phagocytosis of SRBCs by
BMDMs. Nonopsonized or anti-SRBC antiserum opsonized 51Cr-labeled
SRBC were added to cultures of BMDMs derived from HckF/F or HckY/Y mice.
After a 2-h incubation, the cultures were washed extensively and radioactivity
released after lysis of the BMDMs was expressed as a proportion of total radioac-
tivity added to each well. Data represent mean   SD of quadruplicate cultures
from a representative experiment.601 Ernst et al.
Exaggerated Innate Immune Response in HckF/F Mice.
Many of the current gene knock-out models for asthma
suggest that T cells are the main determining factor for es-
tablishing airway responsiveness and that alterations in the
TH1/TH2 balance, irrespective of exogenous factors, may
affect airway behavior. Here, we provide evidence that
baseline abnormalities in lung function can also result as the
cumulative consequence of a mild imbalance in the innate
immune response. The abundance of eosinophils, mucus
cell hyperplasia and elevated levels of IL-5 and eotaxin in
the lungs of HckF/F mice are traits typically associated with
atopic asthma in humans, a chronic inflammatory disorder
of the airways that is associated with reversible airway ob-
struction and bronchial hyper-responsiveness. Macrophage
activation is a frequent but underestimated feature of
chronic asthma (44). As macrophages produce eotaxin (45)
and through their TGF  release can induce cytokine and
chemokine secretion by neighboring cells (e.g., epithe-
lium), we propose that the underlying cause of the asthma-
like pathology observed in HckF/F mice is most likely the
consequence of the hyperresponsive nature of macrophages
within the mice. Thus, the pulmonary response resulting
Figure 9. Enhanced adhesion-dependent ac-
tivity of HckF/F PMNs in vitro. (a) PMNs from
HckF/F (black bars) and HckY/Y (white bars)
mice were seeded in the top well of a modified
Boyden chamber containing a fibronectin-
coated insert studded with 8- M pores. The
chemoattractant fMLP (200 nM) as added to
lower and/or upper well as indicated. After in-
cubation at 37 C for the indicated periods of
time, the inserts were removed, stained with
Giemsa and the number of PMNs that had mi-
grated to the underside of the inserts (left pan-
els) were quantified by counting the number of
cells in five separate fields on two inserts per
time point (right panel). Mean   SD. (b) Acti-
vation and degranulation response of Gr-1–pos-
itive PMNs as determined by FACS® analysis.
HckY/Y (white symbols) and HckF/F PMNs
(black symbols) were either preincubated for 30
min at 37 C in fibrinogen-coated 24-well plates
(“adherent”) or directly stimulated (“suspen-
sion”) with TNF  (20 ng/ml) or PMA (1 mg/
ml). Cells were fixed at the indicated time
points, stained for Gr-1, and changes in forward
scatter (FSC) and side scatter (SSC) profiles was
analyzed (left panels). The percentage of Gr-1hi
cells with reduced SSC (“degranulation”) and
increased FSC (“activation”) were gated in the
bottom right quadrant. The data shown are
shown from a representative experiment (right
panel). (c) Generation of O2
  is exaggerated in
HckF/F PMNs. PMNs from HckY/Y (white
symbols) and HckF/F (black symbols) mice were
seeded into fibrinogen-coated 96-well plates.
The cells were stimulated with TNF  (20 ng/
ml), fMLP (200 nM), or vehicle and incubated
at 37 C for the indicated periods of time. O2
 
production was then measured as described in
Materials and Methods. The data represents
means   SD from quadruplicate cultures.602 Constitutive Activation of Hck Results in an Enhanced Pulmonary Inflammation
from disregulated tyrosine phosphorylation in the myeloid
cell compartment, and the associated exacerbation of the
inflammatory response, is distinct from those observed in
mouse models where airway hyperreactivity is due to ge-
netic manipulation of the cytokine network, including mu-
tants for IL-4 (46, 47), IL-5 (48), IL-9 (49), IL-13 (46, 50),
eotaxin (51), as well as GM-CSF (52) and its downstream
transcription factor PU.1 (53). In particular, the distinctive
accumulation of eosinophilic material together with Char-
cot-Leyden crystals in the alveolar compartments is an un-
usual observation, even in mice that have intense eosino-
philic inflammation induced by helminthic parasites or
allergen inhalation.
An overwhelming systemic inflammatory response to en-
dotoxin (i.e., LPS) is central to the pathogenesis (e.g., tissue
damage, multi-organ failure, and death) of septic shock.
Macrophage-derived pro-inflammatory cytokines (e.g.,
TNF , IL1 , and GM-CSF) as well as nitric oxide, are
critical mediators of endotoxic shock (54). Adhesion of
PMNs to the vascular endothelium and their extravasation
into the underlying tissue is necessary for endotoxic shock
as mice deficient for ICAM-1 are resistant to LPS-induced
toxic shock (55). Notably, Hck / Fgr /  compound mu-
tant mice are likewise resistant to LPS-induced toxic shock
(10). Thus, the enhanced susceptibility of HckF/F mice to
systemic administration of LPS is likely to be the conse-
quence of constitutive priming of the leukocyte population.
Constitutive Priming of HckF/F Leukocytes? Previous in
vitro analysis of PEMs and BMDMs derived from Hck / 
Fgr /  and Hck / Fgr / Lyn /  compound mutant mice
have functionally placed these SFKs downstream of leuko-
cyte integrins (i.e.,  1- and  2/ 3-integrins in BMDMs
and PEMs, respectively; see references 19 and 56), and up-
stream of the actin cytoskeleton-associated proteins paxillin,
Pyk2, cortactin, and the signaling proteins Syk, c-Cbl, and
PI 3-kinase (57). Accordingly, BMDMs derived from these
compound mutant mice exhibit a defect in cell adhesion
and migration (19, 57). Similarly, PEMs from Hck / Fgr / 
Lyn /  compound mutant mice are defective in adhesion-
dependent priming, culminating in impaired respiratory
burst and degranulation responses to pro-inflammatory cy-
tokines, such as TNF  (15, 56). Although it has been re-
ported that Hck localizes to secretory granules in human
PMNs and thus might potentially regulate the degranula-
tion process (58), TNF -induced degranulation of PMNs
from HckF/F mice was still a cell adhesion–dependent pro-
cess. Thus, we hypothesize that constitutive activation of
Hck partially mimics cytokine (e.g., INF- ) mediated leu-
kocyte priming, characterized by integrin clustering (“in-
side-out” signaling) and increased avidity for ligands (e.g.,
intercellular adhesion molecule 1 [ICAM-1]) on endothelial
cells. In vivo this is likely to result in enhanced tissue inva-
sion by innate cells in response to an inflammatory stimulus
(e.g., bacterial infection), as  2-integrin mediated adhesion
of leukocytes to the endothelium is an important initiation
signal for diapedesis. Indeed, mutations that impair the
function of the  -subunit of the leukocyte integrins predis-
pose individuals to life-threatening infections (59).
Although previous studies of “loss-of-function” models
for SFKs identified circulating macrophages and PMNs as
the major cell types susceptible to impairments in Hck-
mediated signaling, our study suggests that this kinase also
serves a major function in eosinophils. It is well established
that Mac-1 ( m 2; CD11b/CD18 integrin) mediated cell
adhesion is important for eosinophil activation, degranula-
tion, and the secretion (paracrine and autocrine) of eosino-
philopoietic factors (60, 61). Hence,  2-integrin–mediated
priming of eosinophils, either by IL-5–mediated cell adhe-
sion, ligation of Mac-1 or addition of recombinant ICAM-1,
triggered Y-phosphorylation of cbl, paxilin, enhanced cel-
lular degranulation (61), and prolonged eosinophil survival
in vitro (62). Thus, these observations imply that hyperac-
tive HckF protein may also result in “constitutive” eosino-
phil priming, associated with enhanced cellular adhesion
and degranulation.
Mutations in proteins involved in balancing (adhesion-
dependent) cellular tyrosine phosphorylation in myeloid
lineage cells (e.g., SHP1, CD45, SHIP, and CSK) often re-
sult in severe pathologies and associated reduction in the
life spans of the corresponding mutant mice (40, 63–65).
By contrast, dysregulated tyrosine phosphorylation in eo-
sinophils, PMNs, and macrophages caused by the presence
of the HckY499F mutation, appears not to affect the overall
life span of HckF/F mice. Based on documented evidence
for rarely occurring activating somatic nonsense mutations
in the COOH-terminal end of human c-Src (66, 67), it is
tempting to speculate that the hck gene might represent a
potential candidate susceptibility locus in addition to those
associated with allergy and bronchial hyperresponsiveness
on chromosome 5q31-q33 (68).
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